{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T05:00:44Z","timestamp":1780290044155,"version":"3.54.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejim.2026.106765","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T05:05:31Z","timestamp":1771391131000},"page":"106765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["MBL2 deficiency and IgA Nephropathy in transplant patients: Is complement inhibition always beneficial?"],"prefix":"10.1016","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7248-2289","authenticated-orcid":false,"given":"Emma Diletta","family":"Stea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pesce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4973-3523","authenticated-orcid":false,"given":"Ighli di","family":"Bari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7907-7614","authenticated-orcid":false,"given":"Rossana","family":"Franzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausta","family":"Piancone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5132-6532","authenticated-orcid":false,"given":"Fabio","family":"Sallustio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7650-7507","authenticated-orcid":false,"given":"Arianna","family":"De Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1439-7662","authenticated-orcid":false,"given":"Maria Antonietta","family":"Grignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7654-8318","authenticated-orcid":false,"given":"Paola","family":"Pontrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilena","family":"Gregorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8513-8505","authenticated-orcid":false,"given":"Tefik","family":"Islami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5311-9174","authenticated-orcid":false,"given":"Teresa","family":"Rampino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4861-0911","authenticated-orcid":false,"given":"Loreto","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejim.2026.106765_bib0001","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.amjms.2020.10.003","article-title":"IgA nephropathy: an interesting autoimmune kidney disease","volume":"361","author":"Rajasekaran","year":"2021","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.ejim.2026.106765_bib0002","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.semnephrol.2007.10.001","article-title":"Natural history of primary IgA nephropathy","volume":"28","author":"Berthoux","year":"2008","journal-title":"Semin Nephrol"},{"issue":"25","key":"10.1016\/j.ejim.2026.106765_bib0003","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ejim.2026.106765_bib0004","first-page":"575","article-title":"Glomerular diseases: emerging challenges and potential solutions","volume":"9","author":"Canetta","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.ejim.2026.106765_bib0005","first-page":"1415","article-title":"Recurrence of IgA nephropathy after kidney transplantation in adults","volume":"16","author":"Tang","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.ejim.2026.106765_bib0006","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00281-021-00882-9","article-title":"Complement activation in IgA nephropathy","volume":"43","author":"Medjeral-Thomas","year":"2021","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.ejim.2026.106765_bib0007","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3389\/fimmu.2019.00504","article-title":"The emerging role of complement proteins as a target for therapy of IgA nephropathy","volume":"10","author":"Rizk","year":"2019","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.ejim.2026.106765_bib0008","first-page":"291","article-title":"Alternative complement pathway inhibition with Iptacopan in IgA nephropathy","volume":"390","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.106765_bib0009","unstructured":"Novartis Pharmaceuticals. A Phase III multicenter, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of LNP023 in primary IgA nephropathy patients (APPLAUSE-IgAN). ClinicalTrials.gov identifier: nCT04557462."},{"issue":"3","key":"10.1016\/j.ejim.2026.106765_bib0010","first-page":"305","article-title":"Mannose-binding lectin: structure, function, genetics and disease associations","volume":"2","author":"Turner","year":"2000","journal-title":"Rev Immunogenet"},{"issue":"1","key":"10.1016\/j.ejim.2026.106765_bib0011","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1515\/med-2021-0239","article-title":"The ambiguous role of mannose-binding lectin (MBL) in human immunity","volume":"16","author":"Kalia","year":"2021","journal-title":"Open Med (Wars)"},{"issue":"11","key":"10.1016\/j.ejim.2026.106765_bib0012","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1681\/ASN.2017010076","article-title":"Mannose-binding lectin levels could predict prognosis in IgA nephropathy","volume":"28","author":"Guo","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.ejim.2026.106765_bib0013","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1093\/ndt\/13.8.1984","article-title":"Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy","volume":"13","author":"Endo","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.ejim.2026.106765_bib0014","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1681\/ASN.2005090923","article-title":"Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease","volume":"17","author":"Roos","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2026.106765_bib0015","unstructured":"Omeros Corporation. A randomized, double-blind, placebo-controlled, phase 3 study of the safety and efficacy of OMS721 in patients with immunoglobulin A (IgA) nephropathy (ARTEMIS-IGAN). ClinicalTrials.gov identifier: nCT03608033."},{"issue":"2","key":"10.1016\/j.ejim.2026.106765_bib0016","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/ajt.16350","article-title":"DelCFHR3-1 influences graft survival in transplant patients with IgA nephropathy via complement-mediated cellular senescence","volume":"21","author":"Pesce","year":"2021","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.ejim.2026.106765_bib0017","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.ejim.2026.106765_bib0018","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.kint.2015.11.025","article-title":"Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantation","volume":"89","author":"Golshayan","year":"2016","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.ejim.2026.106765_bib0019","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1600-6143.2011.03887.x","article-title":"Mannan-binding lectin mediates renal ischemia\/reperfusion injury independent of complement activation","volume":"12","author":"van der Pol","year":"2012","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.ejim.2026.106765_bib0020","first-page":"1856","article-title":"The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury","volume":"168","author":"Berger","year":"2006","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.ejim.2026.106765_bib0021","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/kisup.2011.10","article-title":"Subclinical rejection in renal transplants is associated with low serum mannose-binding lectin levels","volume":"1","author":"Ibernon","year":"2011","journal-title":"Kidney Int Suppl"},{"issue":"16","key":"10.1016\/j.ejim.2026.106765_bib0022","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/eurheartj\/ehi198","article-title":"Low mannose-binding lectin and increased complement activation correlate to allograft vasculopathy, ischaemia, and rejection after human heart transplantation","volume":"26","author":"Fiane","year":"2005","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.ejim.2026.106765_bib0023","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1002\/eji.200323888","article-title":"Mannose-binding lectin engagement with late apoptotic and necrotic cells","volume":"33","author":"Nauta","year":"2003","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.ejim.2026.106765_bib0024","first-page":"230","article-title":"Mannose-binding lectin and the balance between immune protection and complication","volume":"217","author":"Liu","year":"2012","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.ejim.2026.106765_bib0025","first-page":"151","article-title":"The Lectin Pathway of the Complement System\u2014Activation, Regulation, Disease Connections and Interplay with Other (Proteolytic) Systems","volume":"14","author":"Dob\u00f3","year":"2024","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.ejim.2026.106765_bib0026","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1681\/ASN.2019050515","article-title":"CFHR Gene Variations Provide Insights in the Pathogenesis of the Kidney Diseases Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy","volume":"31","author":"Zipfel","year":"2020","journal-title":"J Am Soc Nephrol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526000701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526000701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T04:12:55Z","timestamp":1780287175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620526000701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":26,"alternative-id":["S0953620526000701"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106765","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MBL2 deficiency and IgA Nephropathy in transplant patients: Is complement inhibition always beneficial?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106765","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106765"}}